IndraLab
Statements
reach
"As a PKM2 inhibitor, Shikonin can prevent muscle cell pyroptosis by indirectly inhibiting the activation of the NLRP3 inflammasome (82, 111), potentially providing therapeutic benefits in idiopathic inflammatory myopathies.Some other NLRP3 inhibitors have been studied for other metabolic and autoimmune diseases, but have not been tested in the context of IIM."